NEW YORK (GenomeWeb News) - Genome Corp., a sequencing start-up based in Providence, RI, has received a $250,000 seed capital investment from the Slater Technology Fund, the companies said today.
 
Genome Corp. was founded earlier this year to develop and commercialize a sequencing method it calls “massively parallel Sanger sequencing,” a single-molecule approach that is expected to "greatly accelerate the speed and significantly reduce the cost of genome sequencing," according to the firm.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.